On September 6, 2022 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following conferences in September (Press release, Iovance Biotherapeutics, SEP 6, 2022, View Source [SID1234619044]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Healthcare Conference
Fireside Chat: September 7 at 2:35 p.m. ET
Boston, MA
HC Wainwright Annual Global Investment Conference
Presentation: On demand beginning September 12 at 7:00 a.m. ET
Virtual and New York, NY
Baird Global Healthcare Conference
Fireside Chat: September 13 at 9:40 a.m. ET
New York, NY
Cantor Oncology, Hematology & HemeOnc Conference
Panel: Cell Therapy in Solid Tumors, September 28 at 1:45 p.m. ET
New York, NY
The live and archived webcasts will be available at View Source